FAIRFIELD, N.J., June 28, 2012 /PRNewswire/ -- Aperture
Health, Inc. (OTC: APRE) announced today that Comprehensive
Geriatric Medicine, P.C., which is doing business as Doctors on
Call, and was selected by the Centers for Medicare and Medicaid
Services ("CMS") as one of only sixteen (16) private medical
practices nationwide to participate in the Independence At Home
Demonstration program ("IAHDP"), is likely to become the driving
force behind revenue generation for the company post merger.
IAHDP was envisioned and deployed as part of the Patient
Protection and Affordable Care Act, intended to assign the medical
practice greater accountability for all aspects of patient care at
home. Private medical practices chosen by CMS to participate
in IAHDP will be monitored for maintaining quality care standards
and reducing overall healthcare costs associated with the patients
enrolled in the program.
Doctors on Call, led by physicians along with nurse
practitioners will provide primary care visits at patient homes,
particularly those with multiple chronic conditions and functional
limitations. With a focus on providing timely and appropriate
care in order to improve quality of care and quality of life for
patients; while lowering care costs via maintaining the patient at
home for as long as possible.
Dr. Paul Rosenstock, MD, Doctors
on Call's CEO, has led the company to become a premier provider of
private medical services to patients at home, currently generating
$2,000,000.00 in annual revenues with
a history of rapid revenue and profit growth year over year.
Additionally, the company is near completion of its first
Diagnostic Urgent Care Private Practice Site, which the company's
management projects will help the company reach a projected revenue
milestone of over $14,000,000.00 in
eighteen (18) months from start up. With plans for at least
two (2) additional such sites coupled with the services of Triad
Therapeutics, Aperture's wholly owned home infusion subsidiary, Dr.
Rosenstock envisions a very strong future for both entities.
James Hennig, R.Ph, Aperture's
CEO and Chairman of the Board of Directors, reiterated and
added, "By combining the clinical and business management
expertise of Aperture Health and Doctors on Call, we open
additional pathways to medical and pharmaceutical service offerings
to homecare patients throughout the NY and NJ
areas. Joining forces will allow for a more seamless
'transition of care' process for patients from comprehensive
physician evaluation through the initiation of pharmaceutical care
at home. We anticipate greater leveraging of each
subsidiaries' core competency in an effort to accelerate revenue
generation and profitability."
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad
Therapeutics operates a fully JCAHO accredited home IV therapy
company, achieving this "gold standard" status in 2007. The
company has built a well respected reputation in its industry for
its therapy expertise and commitment to care for its patient
clients. The company services clients throughout the States
of New Jersey, New York and Connecticut, providing opportunity for organic
growth. Patient referrals are made from physicians,
hospitals, insurance companies, veterinarians and hospice care
providers that have established a professional rapport with
Triad.
Safe Harbor
Certain statements in this news release are
forward-looking, including (without limitation) growing revenues
and earnings, expected results from current projects and attracting
new business. Undue reliance should not be placed on such
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties and other
unpredictable factors, many of which are beyond the Company's
control. The Company's actual results, performance and trends could
differ materially from those indicated or implied by such
statements as a result of various factors, including (without
limitation) the continued strengthening of Triad's selling and
marketing functions, continued customer satisfaction, contract
renewal, new product development, continued availability of capable
dedicated personnel, continued cost management, success and
availability of acquisitions, availability of financing and other
factors, as well as by factors applicable to most companies such as
general economic, competitive and other business and civil
conditions. Information regarding certain of those and other
risk factors and cautionary statements that could affect future
results, performance or trends is discussed in the Company's OTC
Disclosure Statement and unaudited management financials posted on
www.pinksheets.com . All of the Company's forward-looking
statements are expressly qualified by all such risk factors and
other cautionary statements. The information set forth herein
speaks only as of the date hereof.
SOURCE Aperture Health, Inc.